Cargando…

MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome and related disorders

Mutations in MECP2 cause several neurological disorders of which Rett syndrome (RTT) represents the best‐defined condition. Although mainly working as a transcriptional repressor, MeCP2 is a multifunctional protein revealing several activities, the involvement of which in RTT remains obscure. Beside...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frasca, Angelisa, Spiombi, Eleonora, Palmieri, Michela, Albizzati, Elena, Valente, Maria Maddalena, Bergo, Anna, Leva, Barbara, Kilstrup‐Nielsen, Charlotte, Bianchi, Federico, Di Carlo, Valerio, Di Cunto, Ferdinando, Landsberger, Nicoletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278541/ https://www.ncbi.nlm.nih.gov/pubmed/32383329 http://dx.doi.org/10.15252/emmm.201910270

Ejemplares similares

Identification of Region-Specific Cytoskeletal and Molecular Alterations in Astrocytes of Mecp2 Deficient Animals
por: Albizzati, Elena, et al.
Publicado: (2022)

Fingolimod Modulates Dendritic Architecture in a BDNF-Dependent Manner
por: Patnaik, Abhisarika, et al.
Publicado: (2020)

Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives
por: Palmieri, Michela, et al.
Publicado: (2023)

MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis?
por: Bellini, Elisa, et al.
Publicado: (2014)

Brain phosphorylation of MeCP2 at serine 164 is developmentally regulated and globally alters its chromatin association
por: Stefanelli, Gilda, et al.
Publicado: (2016)

Author Correction: Brain phosphorylation of MeCP2 at serine 164 is developmentally regulated and globally alters its chromatin association
por: Stefanelli, Gilda, et al.
Publicado: (2021)

MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background
por: Cobolli Gigli, Clementina, et al.
Publicado: (2016)

MeCP2 Affects Skeletal Muscle Growth and Morphology through Non Cell-Autonomous Mechanisms
por: Conti, Valentina, et al.
Publicado: (2015)

Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage
por: Collins, Bridget E, et al.
Publicado: (2022)

The relationship of Rett syndrome and MECP2 disorders to autism
por: Neul, Jeffrey Lorenz
Publicado: (2012)

Multimodal Neuroimaging in Rett Syndrome With MECP2 Mutation
por: Kong, Yu, et al.
Publicado: (2022)

New Views of the DNA Repair Protein Ataxia–Telangiectasia Mutated in Central Neurons: Contribution in Synaptic Dysfunctions of Neurodevelopmental and Neurodegenerative Diseases
por: Briguglio, Sabrina, et al.
Publicado: (2023)

What We Know and Would Like to Know about CDKL5 and Its Involvement in Epileptic Encephalopathy
por: Kilstrup-Nielsen, Charlotte, et al.
Publicado: (2012)

Spectrum of MECP2 mutations in Vietnamese patients with RETT syndrome
por: Le Thi Thanh, Huong, et al.
Publicado: (2018)

Structural investigation of Rett-inducing MeCP2 mutations()
por: Spiga, Ottavia, et al.
Publicado: (2018)

Rett mutations attenuate phase separation of MeCP2
por: Fan, Chunyan, et al.
Publicado: (2020)

The Molecular Functions of MeCP2 in Rett Syndrome Pathology
por: Sharifi, Osman, et al.
Publicado: (2021)

MeCP2: The Genetic Driver of Rett Syndrome Epigenetics
por: Good, Katrina V., et al.
Publicado: (2021)

Splicing Mutations Impairing CDKL5 Expression and Activity Can be Efficiently Rescued by U1snRNA-Based Therapy
por: Balestra, Dario, et al.
Publicado: (2019)

When Rett syndrome is due to genes other than MECP2
por: Percy, Alan K., et al.
Publicado: (2018)

Genetic Analysis of MECP2 Gene in Iranian Patients with Rett Syndrome
por: NASIRI, Jafar, et al.
Publicado: (2019)

Characterization of Rett Syndrome-like phenotypes in Mecp2-knockout rats
por: Wu, Yang, et al.
Publicado: (2016)

Extrasynaptic N-Methyl-d-aspartate (NMDA) Receptor Stimulation Induces Cytoplasmic Translocation of the CDKL5 Kinase and Its Proteasomal Degradation
por: Rusconi, Laura, et al.
Publicado: (2011)

Mecp2-Null Mice Provide New Neuronal Targets for Rett Syndrome
por: Urdinguio, Rocio G., et al.
Publicado: (2008)

Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome
por: De Felice, Claudio, et al.
Publicado: (2014)

Rett syndrome – biological pathways leading from MECP2 to disorder phenotypes
por: Ehrhart, Friederike, et al.
Publicado: (2016)

MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome
por: Jin, Xu-Rui, et al.
Publicado: (2017)

Glial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome
por: Kahanovitch, Uri, et al.
Publicado: (2019)

De novo mosaic MECP2 mutation in a female with Rett syndrome
por: Alexandrou, Angelos, et al.
Publicado: (2019)

MeCP2 mutations: progress towards understanding and treating Rett syndrome
por: Shah, Ruth R., et al.
Publicado: (2017)

MeCP2 in the regulation of neural activity: Rett syndrome pathophysiological perspectives
por: Cuddapah, Vishnu Anand, et al.
Publicado: (2015)

CDKL5 localizes at the centrosome and midbody and is required for faithful cell division
por: Barbiero, Isabella, et al.
Publicado: (2017)

Blood–Brain Barrier Integrity Is Perturbed in a Mecp2-Null Mouse Model of Rett Syndrome
por: Pepe, Giuseppe, et al.
Publicado: (2023)

MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome
por: Tai, Derek J. C., et al.
Publicado: (2016)

Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice
por: Heckman, Laura Dean, et al.
Publicado: (2014)

MECP2 germline mosaicism plays an important part in the inheritance of Rett syndrome: a study of MECP2 germline mosaicism in males
por: Wen, Yongxin, et al.
Publicado: (2023)

Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism
por: Swanberg, Susan E., et al.
Publicado: (2009)

MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy
por: Rastegar, Mojgan, et al.
Publicado: (2009)

A novel DNA-binding feature of MeCP2 contributes to Rett syndrome
por: Xu, Xin, et al.
Publicado: (2013)

Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands
por: Bueno, Carlos, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9qljerefnas2gd805k80u5kjh5